Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Uterine Cervical Neoplasms 2Advanced Solid Tumours 2Vaginal Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Previously Treated Non Small Cell Lung Cancer 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Endometrioid 1Blast Crisis 1Advanced Solid Tumors 1

Interventions

adavosertib 2factor IX, factor VII, factor X, prothrombin drug combination 1drug XX Z 1ceralasertib 1Rifampin 1Omeprazole 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Advanced Solid Tumours × adavosertib × Clear all
NCT04959266 2022-09-16

A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

AstraZeneca

Phase 1 Terminated
5 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT04949425 2022-09-02

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡